Glaucoma is due to increased fluid pressure in the eye. The chronic open angle type of glaucoma develops slowly as compared to the rather sudden onset narrow angle type which can be associated with redness, pain and nausea. Glaucoma can result in damage to the optic nerve and subsequent blindness and is considered irreversible once advanced. It affects 10% of people older than 80.

At Cell Surgical Network®, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) for a number of ophthalmologic degenerative conditions including glaucoma. We have evidence that may be effective in mitigating the long term effects of glaucoma. Many of our innovative deployment methods are based on techniques used around the world and also used in the veterinary experience. All of our deployments are performed by a board certified ophthalmologist with decades of medical experience. We have several types of eye injections that are IRB Institutional Review Board approved and we have specially designed a deployment (none directly into the eye) that is best suited for glaucoma which combines systemic with local approaches and emphasizes safety for our patients. The SVF is procured from your own fat as part of a minor outpatient surgery. The entire procedure is done with local anesthesia and takes approximately 3 hours.

We care about our Ophthalmology patients at the Cell Surgical Network® and take pride in the time we provide to our patients to deploy the best investigational protocols to help our patients achieve their goals. At this time, ophthalmology procedures are only available at a few of our centers. Please call our 800 number to find out more information 800-231-0407. Or fill out our Confidential Candidate Application and request California Stem Cell Treatment Center.

Leave Comment